Articles

Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors

Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
Institute of Applied Biosciences, CERTH, Thessaloniki, Greece
Institute of Applied Biosciences, CERTH, Thessaloniki, Greece
Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic
Division of Haematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic
Institute of Applied Biosciences, CERTH, Thessaloniki, Greece
Department of Hematology, Rigshospitalet, Copenhagen, Denmark
Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic
Università Vita-Salute San Raffaele, Milan, Italy;Division of Experimental Oncology and Department of Onco-Hematology, IRCCS, San Raffaele Scientific Institute, Milan, Italy
Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
Università Vita-Salute San Raffaele, Milan, Italy;Division of Experimental Oncology and Department of Onco-Hematology, IRCCS, San Raffaele Scientific Institute, Milan, Italy
Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France
Hematopathology Unit and Department of Hematology, Hospital Clinic, University of Barcelona, Institut d’Investigacions Biomèdiques August Pi iSunyer (IDIBAPS), Barcelona, Spain
Department of Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands
The Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, New York, NY, USA
Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France
Cancer Sciences, Faculty of Medicine, University of Southampton, UK
First Department of Propaedeutic Medicine, University of Athens, Greece
The Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, New York, NY, USA
Department of Hematology, Rigshospitalet, Copenhagen, Denmark
Hematology Department, Nikea General Hospital, Piraeus, Greece
Hematopathology Unit and Department of Hematology, Hospital Clinic, University of Barcelona, Institut d’Investigacions Biomèdiques August Pi iSunyer (IDIBAPS), Barcelona, Spain
Cancer Sciences, Faculty of Medicine, University of Southampton, UK
Department of Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands
Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK
Division of Haematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic
Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France
Università Vita-Salute San Raffaele, Milan, Italy;Division of Experimental Oncology and Department of Onco-Hematology, IRCCS, San Raffaele Scientific Institute, Milan, Italy
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;Institute of Applied Biosciences, CERTH, Thessaloniki, Greece;Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
Vol. 101 No. 8 (2016): August, 2016 https://doi.org/10.3324/haematol.2016.141812